1-(3-chloro-5-(trifluoromethyl)phenyl)-2,2,2-trifluoroethan-1-one NEW

Aflaqualone Intermediate (CAS 1125812-58-9)‌
Google Keywords: Aflaqualone Intermediate, CAS 1125812-58-9, Sedative API Synthesis, CNS Drug Intermediates, GMP Pharmaceutical Manufacturing

🌟 ‌Product Overview‌

‌Aflaqualone Intermediate‌ (CAS 1125812-58-9) is a high-purity chemical intermediate essential for synthesizing ‌Aflaqualone‌, a central nervous system (CNS) agent used in sedative and anxiolytic therapies. This intermediate ensures precise and scalable production of Aflaqualone API, adhering to stringent pharmaceutical quality standards for global drug development.

• ‌Primary Function‌: Serves as a key building block in the multi-step synthesis of Aflaqualone API, enabling controlled chemical reactions.

• ‌Applications‌: Sedative drug manufacturing, CNS disorder therapies, and large-scale API production.

✅ ‌Key Advantages‌

🔹 ‌Ultra-High Purity‌ | ≥99.0% (HPLC/GC verified) | Complies with ICH Q11 guidelines for intermediates.
🔹 ‌Scalable Synthesis‌ | Optimized for high-yield production with minimal impurities, reducing manufacturing costs.
🔹 ‌Regulatory Compliance‌ | Fully characterized (NMR, HRMS, FTIR) to support FDA/EMA filings and GMP audits.

🧪 ‌Applications‌

1. ‌API Production‌: Enables efficient synthesis of Aflaqualone with consistent quality and batch-to-batch reproducibility.

2. ‌Process Optimization‌: Supports R&D in refining synthetic pathways for enhanced efficiency and sustainability.

3. ‌Analytical Testing‌: Used in method validation and quality control during API batch release.

📜 ‌Quality Assurance‌

• ‌Testing Methods‌: HPLC, GC, NMR, HRMS, and FTIR for structural confirmation and purity analysis.

• ‌Standards‌: Meets USP <1086>, EP 10.0, and ISO 9001:2015 certified manufacturing protocols.

📈 ‌Market Trends‌

The ‌global CNS therapeutics market‌ is projected to reach ‌$160.2 billion by 2030‌ (CAGR 5.3%), driven by rising demand for sedatives and anxiolytics in aging populations. Aflaqualone intermediates are critical for accelerating cost-effective production of next-generation CNS drugs.

Advance your CNS drug development with Aflaqualone Intermediate – precision-engineered for purity, scalability, and regulatory readiness.